CANBD Stock Price, News & Analysis
Company Description
CANBD (OTC: CANBD) is a publicly traded drug manufacturers—specialty & generic company in the Healthcare sector. The company has a market capitalization of $11.8M.
CANBD stock has declined 22.5% over the past year.
This page provides a comprehensive overview of CANBD stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
CANBD (CANBD) stock. Over the past 12 months, the stock has lost 22.5%. At a market capitalization of $11.8M, CANBD is classified as a micro-cap stock with approximately 1.9M shares outstanding.
Latest News
CANBD has 10 recent news articles. Key topics include earnings, conferences. View all CANBD news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
CANBD Company Profile & Sector Positioning
CANBD (CANBD) operates in the Drug Manufacturers—Specialty & Generic industry within the broader Healthcare sector.
Investors comparing CANBD often look at related companies in the same sector, including Vencanna Ventures (TPPRF), (GENH), Therapeuticsmd Inc (TXMD), Flora Growth Corp (FLGC), and Im Cannabis Corp (IMCC). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate CANBD's relative position within its industry.